Logo image of LIVN

LIVANOVA PLC (LIVN) Stock Fundamental Analysis

USA - NASDAQ:LIVN - GB00BYMT0J19 - Common Stock

53.19 USD
+1.96 (+3.83%)
Last: 10/3/2025, 10:25:17 AM
Fundamental Rating

5

LIVN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. LIVN has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on LIVN.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year LIVN was profitable.
LIVN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: LIVN reported negative net income in multiple years.
LIVN had a positive operating cash flow in 4 of the past 5 years.
LIVN Yearly Net Income VS EBIT VS OCF VS FCFLIVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.43%, LIVN is in the better half of the industry, outperforming 64.40% of the companies in the same industry.
The Return On Equity of LIVN (-18.82%) is better than 61.26% of its industry peers.
LIVN's Return On Invested Capital of 8.04% is amongst the best of the industry. LIVN outperforms 86.39% of its industry peers.
LIVN had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 8.97%.
The 3 year average ROIC (3.45%) for LIVN is below the current ROIC(8.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -8.43%
ROE -18.82%
ROIC 8.04%
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
LIVN Yearly ROA, ROE, ROICLIVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

With an excellent Operating Margin value of 14.41%, LIVN belongs to the best of the industry, outperforming 83.25% of the companies in the same industry.
In the last couple of years the Operating Margin of LIVN has grown nicely.
With a decent Gross Margin value of 69.07%, LIVN is doing good in the industry, outperforming 76.96% of the companies in the same industry.
In the last couple of years the Gross Margin of LIVN has remained more or less at the same level.
Industry RankSector Rank
OM 14.41%
PM (TTM) N/A
GM 69.07%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
LIVN Yearly Profit, Operating, Gross MarginsLIVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

LIVN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LIVN has been increased compared to 1 year ago.
Compared to 5 years ago, LIVN has more shares outstanding
The debt/assets ratio for LIVN is higher compared to a year ago.
LIVN Yearly Shares OutstandingLIVN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
LIVN Yearly Total Debt VS Total AssetsLIVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

LIVN has an Altman-Z score of 1.43. This is a bad value and indicates that LIVN is not financially healthy and even has some risk of bankruptcy.
LIVN's Altman-Z score of 1.43 is in line compared to the rest of the industry. LIVN outperforms 55.50% of its industry peers.
LIVN has a debt to FCF ratio of 2.66. This is a good value and a sign of high solvency as LIVN would need 2.66 years to pay back of all of its debts.
LIVN's Debt to FCF ratio of 2.66 is amongst the best of the industry. LIVN outperforms 87.96% of its industry peers.
LIVN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
LIVN has a Debt to Equity ratio (0.31) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 2.66
Altman-Z 1.43
ROIC/WACC0.95
WACC8.44%
LIVN Yearly LT Debt VS Equity VS FCFLIVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

LIVN has a Current Ratio of 1.29. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.29, LIVN is doing worse than 79.06% of the companies in the same industry.
A Quick Ratio of 1.09 indicates that LIVN should not have too much problems paying its short term obligations.
The Quick ratio of LIVN (1.09) is worse than 73.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.09
LIVN Yearly Current Assets VS Current LiabilitesLIVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.66%, which is quite good.
The Earnings Per Share has been growing slightly by 1.82% on average over the past years.
Looking at the last year, LIVN shows a quite strong growth in Revenue. The Revenue has grown by 8.23% in the last year.
Measured over the past years, LIVN shows a small growth in Revenue. The Revenue has been growing by 2.94% on average per year.
EPS 1Y (TTM)11.66%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%12.9%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%10.64%

3.2 Future

Based on estimates for the next years, LIVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.46% on average per year.
LIVN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.61% yearly.
EPS Next Y13.47%
EPS Next 2Y11.36%
EPS Next 3Y10.46%
EPS Next 5Y11.46%
Revenue Next Year8.58%
Revenue Next 2Y8.16%
Revenue Next 3Y7.5%
Revenue Next 5Y5.61%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LIVN Yearly Revenue VS EstimatesLIVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
LIVN Yearly EPS VS EstimatesLIVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

LIVN is valuated correctly with a Price/Earnings ratio of 14.61.
LIVN's Price/Earnings ratio is rather cheap when compared to the industry. LIVN is cheaper than 85.86% of the companies in the same industry.
When comparing the Price/Earnings ratio of LIVN to the average of the S&P500 Index (27.86), we can say LIVN is valued slightly cheaper.
The Price/Forward Earnings ratio is 12.73, which indicates a correct valuation of LIVN.
Based on the Price/Forward Earnings ratio, LIVN is valued cheaper than 90.58% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LIVN to the average of the S&P500 Index (23.29), we can say LIVN is valued slightly cheaper.
Industry RankSector Rank
PE 14.61
Fwd PE 12.73
LIVN Price Earnings VS Forward Price EarningsLIVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

86.91% of the companies in the same industry are more expensive than LIVN, based on the Enterprise Value to EBITDA ratio.
87.96% of the companies in the same industry are more expensive than LIVN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.92
EV/EBITDA 11.36
LIVN Per share dataLIVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

LIVN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of LIVN may justify a higher PE ratio.
PEG (NY)1.08
PEG (5Y)8.05
EPS Next 2Y11.36%
EPS Next 3Y10.46%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LIVN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIVANOVA PLC

NASDAQ:LIVN (10/3/2025, 10:25:17 AM)

53.19

+1.96 (+3.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners103.79%
Inst Owner Change-0.36%
Ins Owners0.28%
Ins Owner Change6.28%
Market Cap2.90B
Analysts83.75
Price Target64.9 (22.02%)
Short Float %4.23%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.73%
Min EPS beat(2)13.16%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)13.91%
Min EPS beat(4)-0.89%
Max EPS beat(4)23.08%
EPS beat(8)7
Avg EPS beat(8)17.82%
EPS beat(12)11
Avg EPS beat(12)17.01%
EPS beat(16)14
Avg EPS beat(16)16.29%
Revenue beat(2)2
Avg Revenue beat(2)3.38%
Min Revenue beat(2)2.76%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.98%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.85%
Revenue beat(12)11
Avg Revenue beat(12)3.36%
Revenue beat(16)13
Avg Revenue beat(16)2.63%
PT rev (1m)0%
PT rev (3m)1.36%
EPS NQ rev (1m)0.79%
EPS NQ rev (3m)1.75%
EPS NY rev (1m)0.03%
EPS NY rev (3m)2.82%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)3.41%
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)1.85%
Valuation
Industry RankSector Rank
PE 14.61
Fwd PE 12.73
P/S 2.22
P/FCF 17.92
P/OCF 13.41
P/B 2.59
P/tB 32.15
EV/EBITDA 11.36
EPS(TTM)3.64
EY6.84%
EPS(NY)4.18
Fwd EY7.86%
FCF(TTM)2.97
FCFY5.58%
OCF(TTM)3.97
OCFY7.46%
SpS23.98
BVpS20.56
TBVpS1.65
PEG (NY)1.08
PEG (5Y)8.05
Profitability
Industry RankSector Rank
ROA -8.43%
ROE -18.82%
ROCE 11.23%
ROIC 8.04%
ROICexc 12.44%
ROICexgc 252.77%
OM 14.41%
PM (TTM) N/A
GM 69.07%
FCFM 12.38%
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y4.42%
ROICexc growth 3Y38.42%
ROICexc growth 5Y24.6%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 2.66
Debt/EBITDA 1.5
Cap/Depr 126.11%
Cap/Sales 4.16%
Interest Coverage 250
Cash Conversion 93.41%
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.09
Altman-Z 1.43
F-Score6
WACC8.44%
ROIC/WACC0.95
Cap/Depr(3y)78.91%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.66%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%12.9%
EPS Next Y13.47%
EPS Next 2Y11.36%
EPS Next 3Y10.46%
EPS Next 5Y11.46%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%10.64%
Revenue Next Year8.58%
Revenue Next 2Y8.16%
Revenue Next 3Y7.5%
Revenue Next 5Y5.61%
EBIT growth 1Y77.01%
EBIT growth 3Y51.09%
EBIT growth 5Y22.46%
EBIT Next Year34.28%
EBIT Next 3Y14.67%
EBIT Next 5Y3.21%
FCF growth 1Y465.94%
FCF growth 3Y20.82%
FCF growth 5YN/A
OCF growth 1Y278.91%
OCF growth 3Y21.3%
OCF growth 5YN/A